Actively Recruiting
Treatment as Prevention for Hepatitis C in Iceland
Led by Landspitali University Hospital · Updated on 2020-09-25
1000
Participants Needed
1
Research Sites
799 weeks
Total Duration
On this page
Sponsors
L
Landspitali University Hospital
Lead Sponsor
N
National Center of Addiction Medicine (SAA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The main aim of this study is to test in the Icelandic population the hypothesis that a nationwide treatment program which offers effective treatment to all known cases of Hepatitis C with the aim of halting HCV (Hepatitis C virus) transmission will lead to a reduction in incidence and disease burden associated with chronic HCV infection.
CONDITIONS
Official Title
Treatment as Prevention for Hepatitis C in Iceland
Who Can Participate
Eligibility Criteria
You may qualify if you...
- HCV positive subjects 18 years and older
- Living in Iceland
- Covered by the Icelandic Health Insurance
You will not qualify if you...
- Age under 18 years
- Inability to sign informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Landspitali
Reykjavik, Iceland
Actively Recruiting
Research Team
R
Ragnheidur Fridriksdottir, B.Sc, MA
CONTACT
H
Halla Arnardottir, B Sc
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here